Tag: FDA inspections
2
FebruaryQuality concerns: when clinicians question generic manufacturing
Clinicians are raising alarms about the quality of generic drugs made overseas, especially in India and China. Studies show higher rates of adverse events, supply chain risks, and inspection gaps-raising urgent questions about safety, transparency, and the future of affordable medicine.
Recent posts
-
17 Dec 2025
The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
-
10 Dec 2025
Common Pharmacy Dispensing Errors and How to Prevent Them
-
10 Oct 2025
How Liver Failure Increases Heart Disease Risk
-
26 Oct 2025
Nitroglycerin vs Alternatives: What Works Best for Angina and Heart Pain
-
24 Jan 2026
Blood Pressure Medication Safety in Older Adults: How to Avoid Orthostatic Hypotension Risks